KRISTEN JANES, PMP, CHIE 503-***-****

www.linkedin.com/in/kristenjanes adzk4f@r.postjobfree.com

Expert in strategic planning, business transformation processes, portfolio management, change management, vendor procurement and negotiations, for complex public, private and technology management.

Proven skills:

• Project management of complex projects requiring a thoughtful balance of business objectives and patient outcomes

• Strategic long-range planning for health plans managed care pathways and technologies using genomic data analysis

• Business Case Development and Change Management

• Initiating & managing portfolios of programs and products to achieve strategic objectives at for-profit and non-profit companies

• Promoting industry standards and automation concepts at all levels using patient-centered design

• Culturally sensitive and naturally supportive people management skills

• Technical assessment, innovation alignment, and acquisition of technology at all computing layers.

• Change management and Product Life Cycle Management utilizing PMI, Agile, Lean, ISO, Carnegie Mellon Capability Maturity Model, Value Chains, KPI and Balanced Scorecard techniques. BABYLON HEALTHCARE, AUSTIN, TX 2021-2022

VALUE BASED CARE CREATING AI AND DIGITAL HEALTH SOLUTIONS PMO and Client Delivery Program Management

Set up an international Agile PMO delivering best practices, tools, templates and audience based communications. Reduced client delivery implementation time by 25% using lean quality methods on proposal management phase. Measured deliverables and improved overall budgets for all client delivery encompassing one billion dollars in revenue. Provided on-going staff training on how to evaluate features and strategic business opportunities. Collaborated with commercial, clinical operations and product engineering PMO leaders to streamline delivery, refine roles and eliminate duplicate efforts improving margins. Coached team on ISO 13485 medical device audit procedures. Led a business proposal to change client delivery from an overhead line item to a profit center. Led Data Governance Board in support of artificial intelligence gathering and predictive analytics. KAISER PERMANENTE, OAKLAND, CA 2015-2021

MANAGED CARE COMPANY WITH 12.4 MILLION MEMBERS

Director of Genomic Strategy and Implementation, National Quality Planned development of KP’s first detailed interregional genetic vision and strategic plan to improve clinical genetic services and genetic testing. Coordinated an executive leadership team co-chaired by CMO and SVP of Quality to establish an expanded strategy for genomic applications within precision medicine. Managed a portfolio of projects encompassing three strategic pillars; creating evidence-based population management care pathways, facilitating inter-regional collaboration to improve care quality and implementing the IT enabling infrastructure needed to support complex structured genomic data and analytics. Reduced the external genetic laboratory cost per test by 30% using data analytics. Reduced waste annually by evaluating evidence and actionability of new genomic tests and targeting tests which could be done internally. Led KP’s development and secured funding for KP’s Precision Medicine/Genomics IT strategy. The strategy creates the next generation of capabilities including a research program to develop large-scale datasets with linked next generation sequencing and longitudinal phenotypic (EHR, claims, etc.) data in targeted therapeutic areas. Managed KP's CDC Tier 1 Initiative designed to identify patients with hereditary breast and ovarian cancer, Lynch syndrome and Familial Hypercholesterolemia. The program is supported by a team of hereditary cancer patient advisors working in concert with clinicians to design needed workflows. The program's goal is to find the adult carriers before they become symptomatic and provide preventive care improving outcomes when disease presents or avoiding disease altogether. The patient centered design is funded by a combination of care delivery business cases and a Lokahi Grant. Co-wrote and secured a Garfield grant for KP Research whose aims included: Identifying attitudes, barriers, and facilitators to returning genomic information in both the clinical and life science research contexts in cooperation with KP Research Bank. KRISTEN JANES, PMP, CHIE 503-***-****

www.linkedin.com/in/kristenjanes adzk4f@r.postjobfree.com RESOURCES GLOBAL PROFESSIONALS, SAN FRANCISCO, CA 2012-2015 PROFESSIONAL SERVICES CONSULTING FIRM

Strategic Planning Consultant for Kaiser Permanente, National Quality Shaped a new program management office through engagement with Kaiser Permanente’s regional laboratory leadership via a national summit meeting of vice presidents, directors and selected managers structured to identify pain points and the most important business benefits needed in the labs. Collaborated to create on-going planning and governance structure among regional leaders to share best practices and rapidly spread technology innovation. Wrote $20M business plan to upgrade genetic laboratories and managed negotiation terms to implement an enterprise-wide genetic laboratory information system. Blue Shield of CA, San Francisco, CA 2010-2011

$9.7B PAYOR WITH 3.5 MILLION MEMBERS

Program Management Consultant

Planned resources, schedule, quality, and budget including vendor management for $14 million 5010 remediation implementations. Executed conversion of 5010 transactions into and out of Blue Shield’s legacy mainframe ensuring transactions aligned with Medicare and CHIP requirements. Managed offshore resources and program risk for 27 impacted IT application managers presenting monthly updates to CIO and executive IT staff. STRATEGIC ARTISTRY, PORTLAND, OR 2008-2010

CONSULTANT

Board Chair and Strategic Consultant

Breast Friends, Inc. – Synthesized board vision into data-driven strategic planning objectives with metrics for success using a balanced scorecard. Successfully expanded the program nationally. Elected to board and retired as Chair in 2012.

INTEL CORPORATION, PORTLAND, OR 1997-2006

$38B PLATFORM TECHNOLOGY COMPANY

Director of Business Development

(New Business Investment Group) - Led over 50 international engagements for 12 different business groups in a single year. As director, ran negotiations and contract creation for each engagement encompassing capital acquisition, technology analysis, licenses, service agreements, and vendor management. Director of Strategic Planning

(Product Planning and Initiatives Group) - Restructured the corporate business planning process involving a new vertical market product planning approach encompassing all 26 Divisions. Executive and employee bonuses rested on improving customer satisfaction by reducing the frequency of roadmap changes throughout Intel’s $38B product line and the development of new user interfaces increasing the use of graphics, AI and speech recognition to drive the demand for more computing power. Planning encompassed finance, research, development, manufacturing, software industry development and marketing business plan alignment. The process culminated in a 2-day board event to review all plans. Director of Program Management and Business Development .NET/Java Strategy

(Software Solutions Group) - The strategy achieved a billion dollar uplift for Intel. Analyzed, modeled and organized requirements and solutions orchestrating the needs of the CTO, VP’s of software and business division VP’s in support of differentiated product performance. Managed a portfolio of programs encompassing universities and vertical industry leaders. Led negotiations for multimillion-dollar agreements covering engineering and strategic marketing programs with major industry customers and competitors (Sun, IBM, Oracle, and HP). Quality Officer

(Systems Management Division) – Increased customer satisfaction from below 50% to 86% Vendor of Choice, grew OEM channel revenue by $3.5M product sales increased from $25 to $32M in 18 months. Managed the program management operations for 300 engineers. Matured the development practices in engineering and marketing using the CMMI model. Responsible for resourcing, budgeting, and scheduling of product launches. Reduced time to money by half across multiple new product lines. Reduced number and frequency of critical errors release on release while identifying areas for software re-use. The division achieved CMMI Level 3. KRISTEN JANES, PMP, CHIE 503-***-****

www.linkedin.com/in/kristenjanes adzk4f@r.postjobfree.com Education, Certifications, Memberships

B.S., HEALTHCARE ADMINISTRATION MANAGEMENT

PROGRAM MANAGEMENT INSTITUTE- PROFESSIONAL CERTIFICATION NO .1390437 FELLOW KP CERTIFIED HEALTH INSURANCE EXECUTIVE - AHIP PROFESSIONAL CERTIFICATION FELLOW - KAISER PERMANENTE STRATEGIC LEADERSHIP PROGRAM 2014 - KELLOGG SCHOOL OF BUSINESS EXECUTIVE MBA PROGRAM

FELLOW – KP QUALITY - NAHQ 2019

Life Science Publications

Freeman, A., Powell, C. Kutner, S., Janes, K. (2016 October 1). Cost Savings of Population Based Genetic Testing among Ashkenazi Jewish Adult Females in Northern California. Gynecologic Oncology, 143, 195-196. doi: 10.1016/j.ygyno.2016.08.245

Blum-Barnett, E., Carroll, N.M., Madrid, S.D., Jonas, C. Janes, K., Alvarado, M., Bedoy, R., McGlynn, E.A. Burnett-Hartman, A. (Presented at ACMG 2019 March). Policies on Return of Research-Related Genetic Test Results Differentially Impact Willingness to Participate by Race/Ethnicity. Institute for Health, Kaiser Permanente. Jonas, C., Suwannarat, P., Burnett-Hartmann, A., Carroll., N., Turner, M., Janes, K., Truing, C., Blum-Barnett, E., Aziz, N., McGlynn, E. ( 2019, November). Physician Experience with Direct-to-Consumer Genetic Testing in Kaiser Permanente, Journal of Personalized Medicine, 9,47. doi:10:3390/pm9040047. Le,A., Valice, E., Kobelka, C., Janes, K., Hoodfar,E., Powell, C. (2020, March 1). A Pilot Study of an Online Screening Tool to Identify Women with Inherited Cancer Risk. Gynecologic Oncology. doi: DO - 10.1016/ j.ygyno.2019.11.088

Burnett-Hartman, A., Blum-Bartnett, E., Carroll, N., Madrid, S.D., Cabell, J., Janes, K., Alvarado, M., Bedot, R., Paolino, V., Aziz, N. McGynn, E. (2020, April 14). Return of Research-Releated Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups. Public Health Genomics, 23. doi: 10.1159/000507056.

Le,A., Valice, E., Kobelka, C., Janes, K., Hoodfar,E., Powell, C. (2021, June 10). Electronic Family History Screening Tool for Detection of Inherited Cancer Risk: A Prospective Pilot Study. American Journal of Medical Quality. doi:10.1097/01.JMQ.0000735504.65700.25

Contact this candidate